The Christopher Klebanoff Lab | Memorial Sloan Kettering Cancer Center

[Placeholder Image]

The Klebanoff Laboratory is a translational research team focused on the development of adoptive T-cell based immunotherapies for patients with breast cancer and other solid malignancies.

Christopher A. Klebanoff

Christopher A. Klebanoff

Research Focus

Physician-scientist Christopher A. Klebanoff studies T cell immunobiology with an emphasis on adoptive T cell immunotherapy for the treatment of solid malignancies.

View Christopher A. Klebanoff’s profile.

Lab Members

Smita Chandran — Smita Chandran

Senior Research Scientist

Matthew Femia — Matthew Femia

Research Technician

Fei Yi — Fei Yi

Research Fellow

Research Projects

About Projects

Publications

Klebanoff, C.A., Rosenberg, S.A., Restifo, N.P. Prospects of gene-engineered T cell immunotherapy for solid cancers. Nature Medicine, 22: 26-36, 2016.
Klebanoff, C.A., Scott, C.D., Leonardi, A.J., Yamamoto, T., et al. Memory T cell–driven differentiation of naive cells impairs adoptive immunotherapy. Journal of Clinical Investigation, 126: 318-334, 2016.

Affiliations

Selected Achievements

NIH Fellows Award for Research Excellence (2013)
NCI/Center for Cancer Research Post Doctoral Research Fellow of the Year (2011)
AOA National Medical Honor Society (2006)
Howard Hughes Medical Institute continuing support scholarship (2004-2006)
Merk Index Award (2000)

Career Opportunities

Former Lab Members

Patricia Lopez